All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
TOKYO – Japan has made great strides in speeding drug and device approvals, but there are concerns that fewer products are coming to market despite the visible regulatory improvements over the past decade.